Quarterly Outlook
Macro Outlook: The US rate cut cycle has begun
Peter Garnry
Chief Investment Strategist
Global Macro Strategist
Summary: Once again - & likey the norm for a while - we tune into the latest updates & thoughts around the Novel Coronavirus (a.k.a 2019-nCoV / Wuhan Coronavirus). We also preview on the BoE & the likely non-consensus legacy cut that will be Mark Carney's last meeting as governor. We then also lightly touch on the Fed statement overnight - with comments on the Virus as well as Repo / Liquidity operations. Macro Dragon = Daily Cross-Asset Global Views
2020-Jan-30
The Committee will advise the Director-General on whether the outbreak constitutes a Public Health Emergency of International Concern (PHEIC), and what recommendations should be made to manage it.
The Director-General’s decision, following the Committee’s advice, will be made public on WHO’s website and via a press conference. The recommendations will also be made public.
-
-
-
Have a great wk everyone, good luck on the month close & start, stay healthy as well as keep your mind open to profitable & abundant opportunities.
Mon 3 Feb could be a big wake up call for the US voter & more importantly for us on Macro Dragon, US equities (i.e. we are only -1.9% from Jan 22 ATH of 3338) & market risk contagion.
Namaste,
-KVP
-
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)